Although it had minimal effect on TIMP-1, the MMP-1/TIMP-1 ratio increased significantly after DHLA treatment, shifting these SSc cells from a profibrotic state to a relatively antifibrotic state. This evidence concerns the gene MMP1 and systemic sclerosis.